Posterior reversible encephalopathy syndrome (PRES) and myeloma

被引：1

作者：

Ghanem, Ricardos ^{[1
]}

Glaisner, Sylvie ^{[2
]}

Bobin, Arthur ^{[3
]}

Cereja, Sophie ^{[1
]}

Joly, Bertrand ^{[1
]}

Salanoubat, Celia ^{[1
]}

Fouquet, Guillemette ^{[1
,4
]}

机构：

[1] Ctr Hosp Sud Francilien, Hematol Clin, Corbeil Essonnes, France

[2] Inst Curie, Dept Oncol Med, Paris, France

[3] CHU Poitiers, Serv Hematol & Therapie Cellulaire, Pole Reg Cancerol, Poitiers, France

[4] Univ Paris, Inst Cochin, INSERM U1016, CNRS,UMR8104,Fac Med Cochin Port Royal, Paris, France

来源：

LEUKEMIA RESEARCH REPORTS | 2024年 / 21卷

关键词：

Myeloma; Neurotoxicity; Cerebrovascular complication; Posterior reversible encephalopathy syndrome; Chemotherapy; MULTIPLE-MYELOMA; PATIENT; CARFILZOMIB;

D O I：

10.1016/j.lrr.2023.100407

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Posterior reversible encephalopathy syndrome (PRES) has rarely been described in myeloma, but chemotherapy is a known risk factor. We report 3 patients with myeloma who developed PRES, and analyzed them with 13 published cases, mostly women. The most frequent causative agents were proteasome inhibitors and autologous stem cell transplantation. Risk factors were frequently associated: hypertension, infection or renal failure. Symptoms included headache, blurred vision, altered mental status, seizures. Most patients experienced rapid clinical recovery, without relapse even after resuming treatment. Although rare, we must remain vigilant about PRES in myeloma patients. Stricter control of blood pressure could limit its occurrence.

引用

页数：4

共 50 条

[41] Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19
Kishfy, Louis
Casasola, Marcel
Banankhah, Peymaan
Parvez, Arshi
Jan, Yu Jen
Shenoy, Anant M.
Thomson, Carey
AbdelRazek, Mahmoud A.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 414
[42] Therapy and differential diagnosis of posterior reversible encephalopathy syndrome (PRES) during pregnancy and postpartum
Cozzolino, Mauro
Bianchi, Claudia
Mariani, Giulia
Marchi, Laura
Fambrini, Massimiliano
Mecacci, Federico
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (06) : 1217 - 1223
[43] Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report
Puram, Vikram V.
Ghazaleh, Dana
Salari, Apameh
McCleary, Kaci
Moriarty, Gerald
Nichols, Kendall
Ghannam, Malik
Brown, Kevin
Berry, Brent
BMC NEUROLOGY, 2022, 22 (01)
[44] Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide
Chow, Signy
Cheung, Christina S.
Lee, Donald H.
Howson-Jan, Kang
Xenocostas, Anargyros
LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 1003 - 1005
[45] Posterior Reversible Encephalopathy Syndrome
Sundin, Courtney Stanley
Johnson, Michelle Laurane
MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2018, 43 (02) : 77 - 82
[46] Posterior reversible encephalopathy syndrome
Fischer, M.
Schmutzhard, E.
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2016, 111 (05) : 417 - 423
[47] Posterior reversible encephalopathy syndrome
Pula, John H.
Eggenberger, Eric
CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (06) : 479 - 484
[48] Posterior Reversible Encephalopathy Syndrome
Johnson, Eric K.
Lin, Michael Y.
HOSPITAL MEDICINE CLINICS, 2015, 4 (03) : 358 - +
[49] Posterior reversible encephalopathy syndrome
Staykov, D.
Schwab, S.
NERVENARZT, 2012, 83 (08): : 1013 - +
[50] Posterior reversible encephalopathy syndrome
Staykov, D.
Schwab, S.
NERVENARZT, 2012, 83 (08): : 1013 - +

← 1 2 3 4 5 →